Dr. Steven Tucker is a hematologist oncologist practicing in Santa Monica, CA. Dr. Tucker specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of Missouri-Columbia School of Medicine 1994
- Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly.
- PSA response to thalidomide in patients with advanced prostate cancer.
- Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappaB signaling.
- The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cells.
- Switching leukemia cell phenotype between life and death.
- Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient.
- Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis.
- cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A.
- Chemical synthesis and biological activities of 3-alkyl pyridinium polymeric analogues of marine toxins.
- Mammalian growth cone turning assays identify distinct cell signalling mechanisms that underlie axon growth, guidance and regeneration.
- Efficient cell transfection with melamine-based gemini surfactants.
- The use of fluorescence resonance energy transfer (FRET) to measure axon growth and guidance-related intracellular signalling in live dorsal root ganglia neuronal growth cones.
- A1-adenosine acute withdrawal response and cholecystokinin-8 induced contractures are regulated by Ca(2+)- and ATP-activated K(+) channels.
- The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell
- POPDC proteins as potential novel therapeutic targets in cancer.
Dr. Steven J Tucker M.D.'s Practice location
Santa Monica, CA 90404Get Direction
Dr. Steven J Tucker M.D.'s reviewsWrite Review
- How This Survivor Star Beat Hodgkin Lymphoma—Twice
Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- What are the Stages of Multiple Myeloma?
This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
- Schools Join the Fight Against Lymphoma and Blood Cancers
Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
- Dr. Nader Javadi M.D.4500 Brockton Ave Riverside CA 92501
- Dr. Barry Rosenbloom M.D.9090 Wilshire Blvd Beverly Hills CA 90211
- Dr. Saeed Sadeghi MD2020 Santa Monica Blvd. Santa Monica California 90404
- Dr. Bahareh Bahadini MD15031 Rinaldi St Mission Hills CA 91345
- Dr. Maurice Julian Berkowitz M.D.2601 W Alameda Ave Burbank CA 91505
- Dr. Omid S. Shaye M.D.7320 Woodlake Ave West Hills CA 91307